Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Pain Symptom Manage. 2016 Sep 21;52(5):695–708.e4. doi: 10.1016/j.jpainsymman.2016.04.014

Table 3.

Differences in Demographic and Clinical Characteristics Between the Lower Fatigue (n= 153) and Higher Fatigue (n= 244) Classes

Characteristic Lower Fatigue Class

n=153
(38.4%)

Mean (SD)
Higher Fatigue Class

n=244
(61.3%)

Mean (SD)
Statistic and p-value
Age (years) 57.8 (11.9) 53.1 (11.0) t=4.09, p<.0001
Education (years) 15.3 (2.5) 15.9 (2.8) t=−2.02, p=.04
Karnofsky Performance Status score 96.6 (7.0) 91.1 (11.4) t=5.86, p<.0001
Self-administered Comorbidity Questionnaire score 3.8 (2.6) 4.6 (3.0) t=−2.64, p=.009
Fatigue severity score at enrollment 1.6 (1.6) 4.1 (2.2) t=−12.55, p<.0001
Number of breast biopsies in past year 1.5 (0.8) 1.5 (0.8) U, p=.47
Number of positive lymph nodes 0.8 (1.9) 1.0 (2.4) t=−0.88, p=.38
Number of lymph nodes removed 4.8 (5.1) 6.4 (7.5) t=−2.43, p=.016
n (%) n (%)
Ethnicity
 White
 Black
 Asian/Pacific Islander
 Hispanic/Mixed ethnic background/Other

100 (65.8)
19 (12.5)
17 (11.2)
16 (10.5)

155 (63.8)
21 (8.6)
32 (13.2)
35 (14.4)
Χ2=2.82, p=.42
Married/partnered (% yes) 64 (42.1) 100 (41.5) FE, p=.92
Work for pay (% yes) 71 (46.4) 118 (49.0) FE, p=.68
Lives alone (% yes) 40 (26.5) 54 (22.4) FE, p=.40
Gone through menopause (% yes) 96 (63.6) 151 (64.3) FE, p=.91
Stage of disease
 0
 I
 IIA and IIB
 IIIA, IIIB, IIIC, and IV

29 (19.0)
66 (43.1)
48 (31.4)
10 (6.5)

44 (18.0)
85 (34.8)
92 (37.7)
23 (9.4)
U, p=.13
Surgical treatment
 Breast conservation
 Mastectomy

123 (80.4)
30 (19.6)

195 (79.9)
49 (20.1)
FE, p=1.00
Sentinel node biopsy (% yes) 130 (85.0) 197 (80.7) FE, p=.34
Axillary lymph node dissection (% yes) 50 (32.7) 98 (40.3) FE, p=.14
Breast reconstruction at the time of surgery (% yes) 33 (21.7) 53 (21.7) FE, p=1.00
Neoadjuvant chemotherapy (% yes) 21 (13.7) 58 (23.9) FE, p=.014
Radiation therapy during the first 6 months (% yes) 87 (56.9) 137 (56.1) FE, p=.92
Chemotherapy during the first 6 months (% yes) 36 (23.5) 97 (39.8) FE, p=.001

Abbreviations: FE = Fisher Exact test, SD = standard deviation, U = Mann Whitney U test